These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
257 related articles for article (PubMed ID: 31294522)
21. Evaluation of a Nurse-Led Program for Rural Pregnant Women With Opioid Use Disorder to Improve Maternal-Neonatal Outcomes. Paterno MT; Jablonski L; Klepacki A; Friedmann PD J Obstet Gynecol Neonatal Nurs; 2019 Sep; 48(5):495-506. PubMed ID: 31374181 [TBL] [Abstract][Full Text] [Related]
22. Breastfeeding reduces the need for withdrawal treatment in opioid-exposed infants. Welle-Strand GK; Skurtveit S; Jansson LM; Bakstad B; Bjarkø L; Ravndal E Acta Paediatr; 2013 Nov; 102(11):1060-6. PubMed ID: 23909865 [TBL] [Abstract][Full Text] [Related]
23. Guideline No. 443b: Opioid Use Throughout Women's Lifespan: Opioid Use in Pregnancy and Breastfeeding. Turner S; Allen VM; Carson G; Graves L; Tanguay R; Green CR; Cook JL J Obstet Gynaecol Can; 2023 Nov; 45(11):102144. PubMed ID: 37977721 [TBL] [Abstract][Full Text] [Related]
24. Analgesia, Opioids, and Other Drug Use During Pregnancy and Neonatal Abstinence Syndrome. Jones HE; Kraft WK Clin Perinatol; 2019 Jun; 46(2):349-366. PubMed ID: 31010564 [TBL] [Abstract][Full Text] [Related]
25. Care and Treatment Recommendations for Pregnant Women with Opioid Use Disorder. Reising VA; Bergren MD; Bennett A MCN Am J Matern Child Nurs; 2019; 44(4):212-218. PubMed ID: 31261299 [TBL] [Abstract][Full Text] [Related]
26. Treatment of Perinatal Opioid Use Disorder. Boyars L; Guille C Obstet Gynecol Clin North Am; 2018 Sep; 45(3):511-524. PubMed ID: 30092925 [TBL] [Abstract][Full Text] [Related]
27. Examination of Hospital, Maternal, and Infant Characteristics Associated with Breastfeeding Initiation and Continuation Among Opioid-Exposed Mother-Infant Dyads. Schiff DM; Wachman EM; Philipp B; Joseph K; Shrestha H; Taveras EM; Parker MGK Breastfeed Med; 2018 May; 13(4):266-274. PubMed ID: 29630387 [TBL] [Abstract][Full Text] [Related]
28. Methadone, Buprenorphine, and Naltrexone for the Treatment of Opioid Use Disorder in Pregnant Women. Tran TH; Griffin BL; Stone RH; Vest KM; Todd TJ Pharmacotherapy; 2017 Jul; 37(7):824-839. PubMed ID: 28543191 [TBL] [Abstract][Full Text] [Related]
29. Obstetric management of women with opioid use disorder. Rosenthal EW; Baxter JK Semin Perinatol; 2019 Apr; 43(3):168-172. PubMed ID: 30711196 [TBL] [Abstract][Full Text] [Related]
30. Neonatal outcomes following in utero exposure to methadone or buprenorphine: a National Cohort Study of opioid-agonist treatment of Pregnant Women in Norway from 1996 to 2009. Welle-Strand GK; Skurtveit S; Jones HE; Waal H; Bakstad B; Bjarkø L; Ravndal E Drug Alcohol Depend; 2013 Jan; 127(1-3):200-6. PubMed ID: 22841456 [TBL] [Abstract][Full Text] [Related]
31. Neonatal Abstinence Syndrome: Advances in Diagnosis and Treatment. Wachman EM; Schiff DM; Silverstein M JAMA; 2018 Apr; 319(13):1362-1374. PubMed ID: 29614184 [TBL] [Abstract][Full Text] [Related]
32. Buprenorphine and methadone for opioid addiction during pregnancy. Mozurkewich EL; Rayburn WF Obstet Gynecol Clin North Am; 2014 Jun; 41(2):241-53. PubMed ID: 24845488 [TBL] [Abstract][Full Text] [Related]
33. Design considerations for point-of-care clinical trials comparing methadone and buprenorphine treatment for opioid dependence in pregnancy and for neonatal abstinence syndrome. Winhusen T; Wilder C; Wexelblatt SL; Theobald J; Hall ES; Lewis D; Van Hook J; Marcotte M Contemp Clin Trials; 2014 Sep; 39(1):158-65. PubMed ID: 25183042 [TBL] [Abstract][Full Text] [Related]
34. Opioid-related treatment, interventions, and outcomes among incarcerated persons: A systematic review. Malta M; Varatharajan T; Russell C; Pang M; Bonato S; Fischer B PLoS Med; 2019 Dec; 16(12):e1003002. PubMed ID: 31891578 [TBL] [Abstract][Full Text] [Related]
35. The Pregnancy Recovery Center: A women-centered treatment program for pregnant and postpartum women with opioid use disorder. Krans EE; Bobby S; England M; Gedekoh RH; Chang JC; Maguire B; Genday P; English DH Addict Behav; 2018 Nov; 86():124-129. PubMed ID: 29884421 [TBL] [Abstract][Full Text] [Related]
36. Transitioning from methadone to buprenorphine maintenance in management of opioid use disorder during pregnancy. Johnson S; Martin PR Am J Drug Alcohol Abuse; 2018; 44(3):310-316. PubMed ID: 28829626 [TBL] [Abstract][Full Text] [Related]
37. Managing opioid dependence in pregnancy -- a general practice perspective. Arunogiri S; Foo L; Frei M; Lubman DI Aust Fam Physician; 2013 Oct; 42(10):713-6. PubMed ID: 24130973 [TBL] [Abstract][Full Text] [Related]
38. Implementing a Learning Collaborative Framework for States Working to Improve Outcomes for Vulnerable Populations: The Opioid Use Disorder, Maternal Outcomes, and Neonatal Abstinence Syndrome Initiative Learning Community. Kroelinger CD; Addison D; Rodriguez M; Rice ME; Frey MT; Hickner HR; Weber MK; Mueller T; Velonis A; Uesugi K; Romero L; Akbarali S; Foster N; Ko JY; Pliska E; Mackie C; Cox S; Fehrenbach SN; Barfield WD J Womens Health (Larchmt); 2020 Apr; 29(4):475-486. PubMed ID: 32176568 [TBL] [Abstract][Full Text] [Related]
39. The Impact of a Prenatal Education Program for Opioid-Dependent Mothers on Breastfeeding Rates of Infants at Risk for Neonatal Abstinence Syndrome. Brocato B; Lewis D; Eyal F; Baker S; Armistead C; Kaye AD; Cornett EM; Whitehurst RM Adv Ther; 2022 Jul; 39(7):3104-3111. PubMed ID: 35522394 [TBL] [Abstract][Full Text] [Related]